CTL-MAT provides nonanimal-based pyrogen testing solutions using the monocyte activation test. Their products and services permit Ph. Eur. 2.6.30-compliant, robust, and accurate detection of pyrogenic contaminants in parenteral drugs, biopharmaceuticals, cosmetics, and solid medical devices. They support their customers with all their MAT-related